NCT00944970View on ClinicalTrials.gov

Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia

PHASE3CompletedINTERVENTIONAL
Enrollment

578

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Coronary Artery Disease
Interventions
DRUG

binodenoson

30-second intravenous injection (bolus) of binodenoson (1.5 mcg/kg) and a 6-minute intravenous infusion of placebo

DRUG

adenosine

30-second intravenous injection (bolus) of placebo and a 6-minute intravenous infusion of adenosine (140 mcg/kg/minute)

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY